The global surgical robot (SR) market climbed to nearly $16 billion in 2025. Analysts project the SR market to top $18 billion in 2026, and is expected to climb to $59 billion by 2034. Below are three different forecasting samples of surgical robot growth:
In 2025, North America dominated the surgical robot market worldwide with a share of 71.46% mainly due to an increase in surgeries; to meet growing demand, more surgeons are training to become robot-assisted surgeons. Another reason for market growth is patient and hospital value. According to patient records, robot-assisted surgery data reveals fewer patient complications and shortened recovery times—patients, hospitals, and hospital staffs all benefit.
Recent surgical robot upgrades include AI software and additional enhancements such as post-surgery analytics for refining surgical techniques, and a variety of real-world surgical training to train more surgeons on the software. Newer robot platforms may include AI-powered navigation, tracking, and vision-based tissue classification in their operation protocols.
These cutting-edge additions improve decision-making for the entire surgical team. Once, surgical robots were only used for prepping patients for surgery. Today they offer tactile feedback with surgical tools that allows the actual surgeon manipulating the robot to feel what the robot’s instruments feel. Such data-driven and post-op analytics can be found on digital screen dashboards—analytics such as motion tracking and performance scoring help clinicians assess outcomes and re-refine techniques over time.
In short, the surgeon operates from real-time data via visual and force-feedback (haptic) sensors, which gives the surgeon the “feel” of actually operating without the extended physical stresses of standing or sitting and operating with a scalpel and other tools for hours, which cause tremors in the hands, wrists, and arms mainly due to muscle fatigue.
While robotic surgery initially took center stage in upscale hospitals and clinics with sizeable budgets, it has also expanded to smaller cities and towns with fewer hospitals and smaller surgical centers. Smaller, mobile surgical robots are a good fit for rural hospitals where typically one or more specialized arms are used by a surgeon via a cart, and where less capital outlay is required.
Today, robotic-assisted surgery accounts for 5% of all surgeries in the U.S.; 2% in Europe, and less than 1% in the rest of the world. Adoption is accelerating in Asia, Latin America, Eastern Europe, and parts of Africa, where the cost of a state-of-the-art da Vinci, the most prodigious of surgical robots thus far, historically remains inaccessible due to its scalable tower platform and price tag. Companies offering lower-cost scalable platforms such as Hugo and Versius are gaining traction in these regions by balancing quality with affordability.
While the surgical robotic field is expanding exponentially, below is a table describing its many current leaders and what types of surgeries they assist.
| Company | System(s) | Surgical Focus | Key Advantage |
|---|---|---|---|
| 1. Intuitive Surgical | da Vinci SP, X, Xi | Soft-tissue (urology, gynecology, general) | Largest installed base, proven outcomes |
| 2. Medtronic | Hugo RAS | oft-tissue (urology, gynecology) | Modular, more affordable, open console |
| 3. CMR Surgical | Versius | General, gynecology, colorectal | Portable, scalable, fits smaller ORs |
| 4. Asensus Surgical | Senhance | General, gynecology, colorectal | Adds haptics to laparoscopy, budget-friendly |
| 5. Stryker | Mako SmartRobotics | Orthopedic (hip, knee) | Leading joint replacement system with CT guidance |
|
6. Zimmer Biomet |
ROSA Knee, ROSA Spine | Orthopedic, neurosurgical | Strong data integration via ZBEdge |
| 7. Smith+Nephew | CORI | Orthopedic (knee arthroplasty) | Compact, ideal for outpatient and ambulatory centers |
| 8. Edge Medical Robotics | In development | Soft-tissue (AI + tactile sensing) | AI-driven, force-sensitive robotics for future use |